Dan HutchesonChief Operating Officer Pfizer
Bill PotterSpecialist in CNS Drug Development NIH
Mark DayGlobal Lead, CNS Search and Evaluation Bristol Myers Squibb
Giora FeuersteinChief Medical and Technical Officer USA Government
Translational CNS Summit, Boston 2013 focused on the biggest commercial opportunity to maximize the value of your CNS pipeline; improving the use of translational approaches.
Unreliable animal models. Validation of new biomarkers. Detecting if a drug has reached the brain. Are all common challenges of CNS drug development.
Translational CNS Summit brought together CNS experts to find solutions to these challenges and more - to improve the translational potential of your entire CNS pipeline. Get more CNS therapies through to market, restore investor and management confidence and bring investment back into the CNS field.
This meeting was fundamentally a summit, a meeting of leading minds in CNS. Attendees meet with and learnt from commercial and academic leaders that inspired new ideas and strategies to help minimize clinical attrition, maximize pipeline potential and see a return on historic investments made in the CNS field.
Attendees of Translational CNS Summit left with a developed ability to:
This meeting was for anyone who wants to be a part of deciding how we can increase the translational potential of CNS therapies. The following represents the spectrum of CNS leaders that were a part of the summit:
To see the brochure from Translationaal CNS Boston, 2013, email firstname.lastname@example.org
“As a small company, we struggle to gain access to high-level drug development executives so the Hanson Wade meetings have been useful to make important contacts that have led to new business and partnership opportunities.” Rules Based Medicine – sponsors of Molecular Dx
“First class meeting – incredible opportunity to meet directly with a broad range of decision makers in this growing field” Quanta Biodesign – sponsors of ADC Summit, Oct 2010 & 2011
“The most profitable event we have ever attended” Immunologix